Search





Search





Markets
/
Stocks
/
mnpr
/

Monopar Therapeutics Inc

MNPR

Add to Watchlist

110.450USD

+0.580+0.53%

Close 07-27 16:00（ET）Quotes delayed by 15 min

739.91MMarket Cap

LossP/E TTM

Monopar Therapeutics Inc

110.450

+0.580+0.53%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

MNPR Cash Flow Statement

You can access the annual and quarterly cash flow statements of Monopar Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

38.66%-3.47M

-68.64%-3.37M

-94.74%-2.09M

35.75%-1.08M

-242.11%-5.66M

-29.27%-2.00M

44.66%-1.07M

20.21%-1.68M

27.11%-1.66M

-18.75%-1.55M

9.71%-1.94M

-60.32%-2.10M

7.96%-2.27M

35.93%-1.30M

-10.67%-2.15M

6.78%-1.31M

-27.32%-2.47M

-63.77%-2.03M

-49.27%-1.94M

-41.25%-1.41M

-72.18%-1.94M

-85.54%-1.24M

-112.07%-1.30M

-34.57%-995.47K

-13.01%-1.13M

-28.79%-668.71K

-2.29%-613.27K

1.74%-739.74K

-23.13%-995.97K

36.37%-519.21K

49.82%-599.56K

-146.74%-752.86K

-159.67%-808.85K

---816.02K

---1.19M

---305.13K

---311.49K

Net income from continuing operations

-48.31%-3.89M

52.40%-5.20M

-163.56%-3.44M

-43.04%-2.45M

-59.94%-2.62M

-502.32%-10.93M

33.24%-1.30M

22.03%-1.72M

32.59%-1.64M

37.37%-1.81M

18.58%-1.95M

20.37%-2.20M

0.90%-2.43M

-8.05%-2.90M

2.39%-2.40M

-32.82%-2.76M

-30.40%-2.46M

-25.94%-2.68M

-49.96%-2.46M

-43.88%-2.08M

-72.71%-1.88M

-76.36%-2.13M

-122.73%-1.64M

-59.63%-1.45M

20.73%-1.09M

-35.53%-1.21M

-14.98%-736.08K

-10.32%-905.70K

-57.04%-1.38M

-24.79%-890.46K

95.70%-640.18K

-38.80%-820.94K

-135.00%-876.35K

---713.58K

---14.88M

---591.44K

---372.92K

Other non-cash items

---799.63K

-123.88%-716.46K

---2.00

----

--3.00M

----

-12239900.00%-122.40K

----

---1.00

--1.00

----

--0.00

--13.50M

----

Change in working capital

89.21%-474.20K

-64.77%1.44M

683.03%247.86K

132.65%96.61K

-1181.39%-4.39M

2086.67%4.10M

106.88%31.65K

21.05%-295.88K

-9.62%-342.86K

-117.17%-206.19K

-229.73%-460.22K

-134.23%-374.77K

38.74%-312.77K

302.35%1.20M

-211.60%-139.57K

245.98%1.09M

-20.91%-510.59K

-56.02%298.52K

126.60%125.06K

281.37%316.46K

-13.15%-422.27K

159.74%678.83K

145.94%55.19K

190.52%82.98K

-354.76%-373.19K

89.03%261.35K

-128.31%-120.14K

-347.31%-91.67K

411.49%146.49K

183.47%138.26K

-138.54%-52.62K

-123.23%-20.49K

-176.56%-47.03K

---165.63K

--136.55K

--88.22K

--61.43K

-Change in prepaid expenses

----

---126.78K

----

-Change in payables and accrued expense

92.39%-287.14K

-82.14%738.68K

1137.63%355.10K

118.92%65.40K

-1111.60%-3.77M

2041.36%4.14M

105.77%28.69K

6.99%-345.75K

-23.54%-311.24K

-117.81%-213.00K

-79.04%-496.89K

-134.03%-371.72K

52.67%-251.92K

251.09%1.20M

-303.62%-277.52K

267.21%1.09M

-43.72%-532.32K

-46.53%340.61K

736.37%136.30K

82.32%297.45K

-11.87%-370.39K

109.37%636.97K

83.45%-21.42K

264.58%163.15K

-297.26%-331.11K

247.06%304.23K

-1050.57%-129.42K

-404.61%-99.13K

889.15%167.85K

436.24%87.66K

-108.34%-11.25K

-61.59%32.54K

-139.49%-21.27K

---26.07K

--134.85K

--84.72K

--53.86K

-Change in other current assets

69.91%-187.04K

1929.87%709.40K

-3720.59%-107.24K

-30.25%34.79K

-1633.39%-621.54K

-669.36%-38.77K

-91.92%2.96K

1735.65%49.87K

41.07%-35.86K

-30.08%6.81K

-72.52%36.67K

-168.64%-3.05K

-352.35%-60.84K

123.14%9.74K

1287.83%133.47K

-76.63%4.44K

146.47%24.11K

-200.54%-42.09K

-114.67%-11.24K

123.70%19.00K

-23.27%-51.88K

197.62%41.86K

726.33%76.61K

-1174.29%-80.17K

-96.98%-42.08K

-184.74%-42.88K

122.41%9.27K

114.07%7.46K

17.05%-21.36K

496.02%50.60K

-2528.11%-41.38K

-1614.05%-53.04K

-440.26%-25.76K

---12.78K

--1.70K

--3.50K

--7.57K

Cash from non-recurring investing activities

Cash from operating activities

38.66%-3.47M

-68.64%-3.37M

-94.74%-2.09M

35.75%-1.08M

-242.11%-5.66M

-29.27%-2.00M

44.66%-1.07M

20.21%-1.68M

27.11%-1.66M

-18.75%-1.55M

9.71%-1.94M

-60.32%-2.10M

7.96%-2.27M

35.93%-1.30M

-10.67%-2.15M

6.78%-1.31M

-27.32%-2.47M

-63.77%-2.03M

-49.27%-1.94M

-41.25%-1.41M

-72.18%-1.94M

-85.54%-1.24M

-112.07%-1.30M

-34.57%-995.47K

-13.01%-1.13M

-28.79%-668.71K

-2.29%-613.27K

1.74%-739.74K

-23.13%-995.97K

36.37%-519.21K

49.82%-599.56K

-146.74%-752.86K

-159.67%-808.85K

---816.02K

---1.19M

---305.13K

---311.49K

Investing cash flow

Net cash flow from investment products

-1613.65%-5.58M

-333.72%-62.19M

-315.68%-2.13M

49100.99%1.19M

66.86%-325.83K

-582.70%-14.34M

7652.33%985.73K

-100.08%-2.42K

0.01%-983.31K

160.39%2.97M

---13.05K

--2.95M

---983.44K

---4.92M

----

Net cash flow from other investing activities

--0.00

--2.53M

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-1613.65%-5.58M

-333.72%-62.19M

-315.68%-2.13M

49100.99%1.19M

66.86%-325.83K

-582.70%-14.34M

7652.33%985.73K

-100.08%-2.42K

0.01%-983.31K

160.39%2.97M

---13.05K

--2.95M

---983.44K

---4.92M

----

Financing cash flow

Cash flow from continuous financing activities

-73.06%-200.20K

-100.69%-384.68K

558897.68%92.39M

-3094.32%-316.85K

-103.64%-115.68K

16679.90%56.14M

-106.70%-16.53K

-101.55%-9.92K

295.36%3.18M

141.14%334.55K

1139.27%246.70K

1079.50%641.18K

4928.98%804.80K

1885.09%138.74K

-137.90%-23.74K

-172.72%-65.46K

-100.15%-16.67K

-8.85%-7.77K

-100.15%-9.98K

-102.54%-24.00K

2049.67%10.92M

-100.08%-7.14K

50810.13%6.73M

7780.60%946.40K

3766.86%508.04K

4650.77%9.39M

---13.28K

---12.32K

---13.86K

-2162.49%-206.27K

-100.00%0.00

--10.00K

--7.50M

--1.04M

--990.00K

Net cash flow from debt Issuance/repayment

----

--0.00

----

--0.00

--122.40K

----

Net cash flow from common stock issuance/repurchase

----

-101.12%-631.39K

--92.77M

--0.00

-100.00%0.00

16436.84%56.20M

-100.00%0.00

----

288.57%3.19M

210.85%339.87K

--254.91K

--657.79K

--821.63K

--109.34K

--0.00

-100.00%0.00

1914.15%10.93M

-100.00%1.00

--6.75M

--879.14K

--542.43K

--10.22M

----

-100.00%0.00

--10.00K

--2.67M

--1.04M

--990.00K

Proceeds from stock option exercised by employees

-100.00%0.00

--544.80K

--214.00

5507.14%4.71K

--15.45K

----

--84.00

----

--0.00

-100.00%0.00

----

--0.00

--128.00

--41.00

-100.00%0.00

--0.00

--17.48K

----

--110.00K

----

--0.00

----

Net cash flow from other financing activities

-52.68%-200.20K

-345.28%-298.09K

-2207.75%-381.56K

-3114.59%-321.56K

-1121.17%-131.13K

-1157.91%-66.95K

-101.46%-16.53K

39.79%-10.00K

36.19%-10.74K

-118.10%-5.32K

65.61%-8.21K

74.64%-16.61K

-0.97%-16.83K

478.28%29.40K

-139.19%-23.87K

-172.89%-65.50K

22.48%-16.67K

-8.84%-7.77K

47.23%-9.98K

56.47%-24.00K

37.47%-21.50K

99.24%-7.14K

-42.38%-18.91K

-347.47%-55.14K

-148.17%-34.38K

-358.31%-945.35K

---13.28K

---12.32K

---13.86K

-20627100.00%-206.27K

----

--1.00

--4.83M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-73.06%-200.20K

-100.69%-384.68K

558897.68%92.39M

-3094.32%-316.85K

-103.64%-115.68K

16679.90%56.14M

-106.70%-16.53K

-101.55%-9.92K

295.36%3.18M

141.14%334.55K

1139.27%246.70K

1079.50%641.18K

4928.98%804.80K

1885.09%138.74K

-137.90%-23.74K

-172.72%-65.46K

-100.15%-16.67K

-8.85%-7.77K

-100.15%-9.98K

-102.54%-24.00K

2049.67%10.92M

-100.08%-7.14K

50810.13%6.73M

7780.60%946.40K

3766.86%508.04K

4650.77%9.39M

---13.28K

---12.32K

---13.86K

-2162.49%-206.27K

-100.00%0.00

--10.00K

--7.50M

--1.04M

--990.00K

Net cash flow

Beginning cash balance

34.96%61.83M

2020.86%127.68M

545.46%39.50M

408.63%39.71M

530.55%45.82M

9.15%6.02M

-15.17%6.12M

36.36%7.81M

-11.24%7.27M

-61.48%5.52M

-56.18%7.21M

-67.87%5.73M

-59.68%8.19M

-35.92%14.32M

-32.23%16.46M

-30.73%17.82M

21.31%20.30M

24.24%22.34M

93.63%24.29M

104.28%25.72M

26.66%16.74M

300.10%17.98M

--12.55M

114.12%12.59M

91.71%13.21M

-41.00%4.49M

-100.00%0.00

-34.46%5.88M

-29.54%6.89M

-28.05%7.62M

91.96%8.22M

152.65%8.97M

240.48%9.78M

--10.59M

--4.28M

--3.55M

--2.87M

Current period cash flow changes

-52.16%-9.29M

-265.45%-65.84M

88410.54%88.18M

87.59%-209.47K

-1227.40%-6.10M

2173.12%39.80M

94.12%-99.85K

-213.33%-1.69M

122.01%541.50K

128.56%1.75M

20.85%-1.70M

209.86%1.49M

0.97%-2.46M

-200.84%-6.13M

-10.04%-2.15M

5.23%-1.36M

-127.65%-2.48M

-63.60%-2.04M

-135.89%-1.95M

-2997.62%-1.43M

1545.70%8.99M

-114.28%-1.25M

955.75%5.44M

93.85%-46.17K

38.56%-621.57K

1301.86%8.72M

-5.82%-635.29K

0.42%-751.24K

-25.08%-1.01M

9.99%-725.49K

-109.52%-600.38K

-203.36%-754.43K

-219.21%-808.85K

---806.02K

--6.31M

--729.91K

--678.52K

Effect of exchange rate changes

-58470.37%-31.63K

2716.22%99.50K

-91.56%376.00

-270.98%-2.55K

96.73%-54.00

54.49%-3.80K

-34.05%4.46K

134.27%1.49K

84.76%-1.65K

82.84%-8.36K

-73.08%6.76K

-120.97%-4.35K

-1545.37%-10.84K

-2556.46%-48.69K

313750.00%25.11K

14928.57%20.76K

-123.76%-659.00

-12.80%1.98K

-99.64%8.00

-104.83%-140.00

168.65%2.77K

85.55%2.27K

125.23%2.21K

252.86%2.90K

-114.83%-4.04K

11236.36%1.23K

-974.91%-8.74K

152.23%821.00

---1.88K

---11.00

---813.00

---1.57K

----

Ending cash balance

32.32%52.54M

34.96%61.83M

2020.86%127.68M

545.46%39.50M

408.63%39.71M

530.55%45.82M

9.15%6.02M

-15.17%6.12M

36.36%7.81M

-11.24%7.27M

-61.48%5.52M

-56.18%7.21M

-67.87%5.73M

-59.68%8.19M

-35.92%14.32M

-32.23%16.46M

-30.73%17.82M

21.31%20.30M

24.24%22.34M

93.63%24.29M

104.28%25.72M

26.66%16.74M

2930.63%17.98M

144.57%12.55M

114.12%12.59M

91.71%13.21M

-108.34%-635.29K

-37.58%5.13M

-34.46%5.88M

-29.54%6.89M

-28.05%7.62M

91.96%8.22M

152.65%8.97M

--9.78M

--10.59M

--4.28M

--3.55M

Free cash flow

38.66%-3.47M

-68.64%-3.37M

-94.74%-2.09M

35.75%-1.08M

-242.11%-5.66M

-29.27%-2.00M

44.66%-1.07M

20.21%-1.68M

27.11%-1.66M

-18.75%-1.55M

---1.94M

---2.10M

---2.27M

---1.30M

----

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Monopar Therapeutics Inc Generate?



Monopar Therapeutics Inc generated -12.20M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Monopar Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Monopar Therapeutics Inc's operating cash flow increased by -90.52% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Monopar Therapeutics Inc's Financing Cash Flow Changed?



Monopar Therapeutics Inc used 91.57M in financing activities in the latest quarter.

What is free cash flow and why does it matter for MNPR?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Monopar Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -12.20M reflecting a -90.52% change from the previous year.